Effects of topical clindamycin on intestinal microflora in patients with acne

https://doi.org/10.1016/S0190-9622(86)70153-9Get rights and content

Thirty-two patients with acne completed a randomized, double-blind study using topical 1% clindamycin phosphate or its vehicle applied twice daily for 8 weeks for a study of its effects on the intestinal microflora. Two clindamycin patients and one vehicle patient had Clostridium difficile in stools prior to therapy. Of the remaining twenty-nine patients, four of nineteen patients who used clindamycin and none of ten patients who used vehicle had C. difficile detected during treatment; the difference was not statistically significant. There was no diarrhea in the clindamycin group, even though clostridial cytotoxin was found transiently in two patients. Self-limited diarrhea occurred in one vehicle-treated patient, whose stool culture was negative but whose stool specimen showed a positive reaction for C. difficile cytotoxin. With the use of a bioassay, clindamycin was not detected in urine or stool of any patient. No significant changes in Bacteroides fragilis counts in stools were observed in either group.

References (24)

  • EB Milstone et al.

    Pseudomembranous colitis after topical application of clindamycin

    Arch Dermatol

    (1981)
  • WL George et al.

    Selective and differential medium for isolation of Clostridium difficile

    J Clin Microbiol

    (1979)
  • Cited by (26)

    • Management of severe acne during pregnancy: A case report and review of the literature

      2017, International Journal of Women's Dermatology
      Citation Excerpt :

      Studies have shown that a combination of benzoyl peroxide and clindamycin is superior to each case individually and may decrease the risk of antibiotic resistance (Lookingbill et al., 1997). It should be noted that rare reports of Clostridium difficile have been seen with patients who were treated with topical clindamycin (Milstone, 1981; Parry, 1986) although it is unclear if this holds true clinical significance (Siegle et al., 1986). Bacteriostatic azelaic acid exerts broad antimicrobial effects via an unknown mechanism and has a well-documented safety profile during pregnancy (Graupe et al., 1996).

    • Topical antibacterial agents

      2000, Infectious Disease Clinics of North America
      Citation Excerpt :

      One potential concern with clindamycin is systemic absorption leading to pseudomembranous colitis. It is estimated that approximately 1% of topical clindamycin phosphate (1% concentration) is absorbed, and there are two case reports of pseudomembranous colitis associated with topical application79; however, two placebo-controlled studies found no increased incidence of diarrhea in patients treated with topical clindamycin compared with placebo.44,95 If there is diminished therapeutic response over time to clindamycin or especially erythromycin, then P. acnes resistance should be considered.88

    • Current concepts in the pathogenesis and treatment of acne

      1998, Journal of Oral and Maxillofacial Surgery
    • Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data

      1998, Journal of the European Academy of Dermatology and Venereology
    • The treatment of acne: The role of combination therapies

      1995, Journal of the American Academy of Dermatology
    View all citing articles on Scopus

    Supported by The Upjohn Co., Kalamazoo, MI.

    View full text